JP2022543058A5 - - Google Patents

Info

Publication number
JP2022543058A5
JP2022543058A5 JP2022506469A JP2022506469A JP2022543058A5 JP 2022543058 A5 JP2022543058 A5 JP 2022543058A5 JP 2022506469 A JP2022506469 A JP 2022506469A JP 2022506469 A JP2022506469 A JP 2022506469A JP 2022543058 A5 JP2022543058 A5 JP 2022543058A5
Authority
JP
Japan
Prior art keywords
tcr
amino acid
muc5ac
acid sequence
constant region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506469A
Other languages
English (en)
Japanese (ja)
Other versions
JP7669345B2 (ja
JP2022543058A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/057171 external-priority patent/WO2021019471A1/en
Publication of JP2022543058A publication Critical patent/JP2022543058A/ja
Publication of JP2022543058A5 publication Critical patent/JP2022543058A5/ja
Application granted granted Critical
Publication of JP7669345B2 publication Critical patent/JP7669345B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506469A 2019-07-30 2020-07-29 T細胞受容体及びその使用方法 Active JP7669345B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962880505P 2019-07-30 2019-07-30
US62/880,505 2019-07-30
PCT/IB2020/057171 WO2021019471A1 (en) 2019-07-30 2020-07-29 T cell receptors and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2022543058A JP2022543058A (ja) 2022-10-07
JP2022543058A5 true JP2022543058A5 (cg-RX-API-DMAC7.html) 2023-08-08
JP7669345B2 JP7669345B2 (ja) 2025-04-28

Family

ID=74230247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506469A Active JP7669345B2 (ja) 2019-07-30 2020-07-29 T細胞受容体及びその使用方法

Country Status (12)

Country Link
US (1) US12624082B2 (cg-RX-API-DMAC7.html)
EP (1) EP4004219A4 (cg-RX-API-DMAC7.html)
JP (1) JP7669345B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220040489A (cg-RX-API-DMAC7.html)
CN (1) CN114450414B (cg-RX-API-DMAC7.html)
AU (1) AU2020320129A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022001695A2 (cg-RX-API-DMAC7.html)
CA (1) CA3146302A1 (cg-RX-API-DMAC7.html)
IL (1) IL290221A (cg-RX-API-DMAC7.html)
MX (1) MX2022001207A (cg-RX-API-DMAC7.html)
TW (1) TWI881993B (cg-RX-API-DMAC7.html)
WO (1) WO2021019471A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020231693A1 (en) 2019-03-04 2021-09-30 University Health Network T cell receptors and methods of use thereof
WO2021019472A1 (en) 2019-07-30 2021-02-04 University Health Network T cell receptors and methods of use thereof
AU2020320129A1 (en) 2019-07-30 2022-03-03 University Health Network T cell receptors and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031916B1 (en) 2007-06-11 2017-06-07 Takara Bio Inc. Method for expression of specific gene
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
EP2622091B1 (en) 2010-09-23 2019-03-13 Precision Biologics, Inc. Colon and pancreas cancer peptidomimetics
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
EP3495483A1 (en) 2012-09-12 2019-06-12 International Institute of Cancer Immunology, Inc. Antigen-specific helper t-cell receptor genes
MX2018001568A (es) 2015-08-07 2019-04-25 Seattle Children´S Hospital Dba Seattle Children´S Res Institute Celulas t biespecificas de receptor quimerico de antigeno (car) para focalizacion a tumores solidos.
KR20180095511A (ko) * 2015-10-30 2018-08-27 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 표적화된 암 요법
JP2019521080A (ja) 2016-04-27 2019-07-25 ユニバーシティ・ヘルス・ネットワーク ペプチド−hla複合体およびその産生方法
CA3076337A1 (en) * 2017-09-19 2019-03-28 Massachusetts Institute Of Technology Compositions for chimeric antigen receptor t cell therapy and uses thereof
AU2020320129A1 (en) 2019-07-30 2022-03-03 University Health Network T cell receptors and methods of use thereof
MX2022001206A (es) 2019-07-30 2022-05-03 Univ Health Network Receptores de linfocitos t y metodos de uso de los mismos.
WO2021019472A1 (en) 2019-07-30 2021-02-04 University Health Network T cell receptors and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2022527267A5 (cg-RX-API-DMAC7.html)
JP2022523552A5 (cg-RX-API-DMAC7.html)
JP2022524993A5 (cg-RX-API-DMAC7.html)
JP2022523971A5 (cg-RX-API-DMAC7.html)
JP2022524994A5 (cg-RX-API-DMAC7.html)
JP2022523554A5 (cg-RX-API-DMAC7.html)
JP2022523553A5 (cg-RX-API-DMAC7.html)
Baxevanis et al. Cancer immunotherapy
CN113286811B (zh) 改善过继性细胞疗法的效力和安全性
CN113784733B (zh) 靶向bcma的工程化免疫细胞及其用途
JP2022524992A5 (cg-RX-API-DMAC7.html)
Kershaw et al. Gene-engineered T cells for cancer therapy
JP2022543059A5 (cg-RX-API-DMAC7.html)
Houot et al. T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition
US20190117692A1 (en) Engager cells for immunotherapy
JP2022531911A (ja) Bcmaを標的とする操作された免疫細胞及びその使用
Zsiros et al. Immunotherapy for ovarian cancer: recent advances and perspectives
Essand et al. Genetically engineered T cells for the treatment of cancer
RU2018147423A (ru) Анти-PD-L1 и IL-2 цитокины
JP2022521183A5 (cg-RX-API-DMAC7.html)
JP2022543060A5 (cg-RX-API-DMAC7.html)
CN108138148A (zh) T细胞的激活和扩增
JP2021512637A5 (cg-RX-API-DMAC7.html)
US11866504B2 (en) Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof
CA3052803A1 (en) Maximizing t-cell memory and compositions and methods therefor